Skip to main content
. 2021 Mar;10(3):1284–1294. doi: 10.21037/tcr-20-2568

Figure 1.

Figure 1

The association between TTN mutation and OS in LUAD and LUSC patients on chemotherapy. (A) Number of patients with TTN mutation in LUAD. (B) Number of patients with TTN mutation in LUSC. (C) The difference in OS between patients with TTN mutation and TTN-WT in LUAD treated with chemotherapy. (D) The difference in OS between patients with TTN mutation and TTN-WT in LUSC treated with chemotherapy. TTN, titin; OS, overall survival; LUAD, lung adenocarcinoma; LUSC, lung squamous carcinoma; MT, mutant-type; WT, wild-type.